Tom Carper actually said...
Additionally, the U.S. bio-pharmaceutical industry has had several patents disregarded, just disregarded, due to inappropriate use of compulsory licensing and patent revocation.
Context
Carper highlights issues with patent rights for U.S. bio-pharmaceuticals in India.
03/18/2013